0001392380-23-000049.txt : 20230801
0001392380-23-000049.hdr.sgml : 20230801
20230801175541
ACCESSION NUMBER: 0001392380-23-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230728
FILED AS OF DATE: 20230801
DATE AS OF CHANGE: 20230801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bloom Paul D
CENTRAL INDEX KEY: 0001854032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35073
FILM NUMBER: 231133057
MAIL ADDRESS:
STREET 1: C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
STREET 2: BUILDING C, SUITE 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gevo, Inc.
CENTRAL INDEX KEY: 0001392380
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 870747704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C
STREET 2: Suite 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: 303-858-8358
MAIL ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C
STREET 2: Suite 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: Gevo Inc
DATE OF NAME CHANGE: 20070307
4
1
wk-form4_1690926931.xml
FORM 4
X0508
4
2023-07-28
0
0001392380
Gevo, Inc.
GEVO
0001854032
Bloom Paul D
C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
BUILDING C, SUITE 310
ENGLEWOOD
CO
80112
0
1
0
0
CCO & CIO
1
Common Stock
2023-07-28
4
S
0
34614
1.6457
D
477968
D
The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 22, 2023. Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.630 to $1.655 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ E. Cabell Massey, Attorney-in-Fact
2023-08-01